TRACON Pharmaceuticals says ENVASARC pivotal trial to proceed as planned after Independent Data Monitoring Committee recommendation
The safety data reviewed included data from more than 10 patients enrolled into cohort A of treatment with envafolimab and more than 10 patients in...